Delivery Order SPE2DB24D2205-SPE2DB24FDUYW

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers, with a ceiling value of $1,573.29. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation. The period of performance runs from the award...
This federal contract award provides for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $4,369.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 11, 2024 with an ultimate completion date of July 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award is for the delivery of Advair HFA 230-21 MCG Inhaler, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 11, 2024, and a ceiling value of $4,526.43. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,671.68 and is a firm fixed price delivery order. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation. The ultimate completion date is August 28, 2024. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the U.S. government. The contract, valued at $5,788.21, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,774.71 and an ultimate completion date of February 21, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition....
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,923.01 firm-fixed-price contract does not have a set-aside designation and was awarded on May 23, 2024, with a completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers, with a ceiling value of $7,052.30. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 15, 2024, with a completion date of February 16, 2024 and a ceiling value of $5,006.46. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $10,470.61 and is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDUYW
    Delivery Order

This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract has a total ceiling value of $4,877.12 and is a firm fixed-price delivery order, with an ultimate completion date of June 4, 2024. The contract was awarded on June 3, 2024, and there is no set-aside designation indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

Generated 9/2/24, 3:57 PM